Inactive Instrument
Pharnext Stock Other OTC
Stocks
PNEXF
FR0011191287
Pharmaceuticals
OTC Markets Traded
| 1 day | -4.20% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Corporate Officer/Principal | - | 2006-12-31 | |
Gilbert Wagener
CTO | Chief Tech/Sci/R&D Officer | - | 2023-06-14 |
Hugo Brugière
CEO | Chief Executive Officer | - | 2022-12-25 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 78 | 2020-07-16 | |
James Kuo
BRD | Director/Board Member | 60 | 2022-06-15 |
| Director/Board Member | 66 | 2023-07-09 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.20% | -.--% | - | - | 39 | |
| -0.53% | -3.95% | +50.70% | +152.78% | 1,024B | |
| +0.21% | -2.68% | +53.20% | +50.87% | 618B | |
| -2.51% | -3.25% | +28.54% | +67.99% | 443B | |
| +0.64% | -0.81% | +40.08% | +33.81% | 349B | |
| -0.96% | -1.43% | +33.94% | +42.24% | 297B | |
| -7.05% | -6.71% | +7.97% | +10.31% | 264B | |
| -0.14% | -5.93% | -1.87% | -42.77% | 209B | |
| -0.64% | +2.43% | +29.74% | +67.16% | 208B | |
| -0.82% | +0.70% | +15.05% | +72.05% | 162B | |
| Average | -0.48% | -1.35% | +28.59% | +50.49% | 397.08B | |
| Weighted average by Cap. | +0.34% | -2.17% | +36.90% | +73.27% |
Employees
-
Sector
Pharmaceuticals
